Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Fogarty, Gerald B ^a,b,f   Hong, Angela ^a,b,f   Jacobsen, Kari Dolven ^c   Reisse, Claudius H ^c   Shivalingam, Brindha ^a,b   Burmeister, Bryan ^e,f   Haydu, Lauren E ^a,d   Paton, Elizabeth ^d   Thompson, John F ^a,b  

^a MELANOMA INSTITUTE AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Australia and New Zealand Gynaecological Oncology Group   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f Trans Tasman Radiation Oncology Group   (Australia)

Author keywords

Brain; Feasibility; Melanoma; Metastases; Pilot project; Radiotherapy; Randomised trial; Trial; Whole brain radiotherapy

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; AUSTRALIA; BRAIN NEOPLASMS; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MELANOMA; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEW ZEALAND; PATHOLOGY; PATIENT SELECTION; PILOT STUDY; RADIOSURGERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY; SKIN NEOPLASMS; SKULL IRRADIATION; SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEW ZEALAND; PATIENT SELECTION; PILOT PROJECTS; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84903330374     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-412     Document Type: Article

References (12)

1. Patterned distribution of metastases from malignant melanoma in humans. De la Monte SM, Moore GW, Hutchins GM, Cancer Res 1983 43 3427 3433 6850649 (Pubitemid 13061609)
2. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. Sampson JH, Carter JH, Friedman AH, Seigler BF, J Neurosurg 1998 88 11 20 10.3171/jns.1998.88.1.0011 9420067 (Pubitemid 28018958)
3. Determinants of outcome in melanoma patients with cerebral metastases. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF, J Clin Oncol 2004 22 1293 1300 10.1200/JCO.2004.08.140 15051777 (Pubitemid 41079844)
4. Metastatic melanoma to the brain: surgery and radiation is still the standard of care. Nicholas S, Mathios D, Jackson C, Lim M, Curr Treat Options Oncol 2013 14 2 264 279 10.1007/s11864-013-0228-6 23504304
5. Poor outcomes after whole brain radiotherapy in patients with brain metastases: results from an international multicentre cohort study. Windsor AA, Koh ES, Allen S, Gabriel GS, Yeo AE, Allison R, van der Linden YM, Barton MB, Clin Oncol (R Coll Radiol) 2013 25 11 674 680 10.1016/j.clon.2013.07.002 23906722
6. Publication and Interpretation of clinical trial results: the need for caution. Thompson JF, Hong A, Fogarty Letter G, Ann Surg Oncol 2012 19 6 1745 1747 10.1245/s10434-012-2350-2 22476820
7. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients-a randomised phase III trial. Fogarty G, Morton RL, Vardy J, Nowak AK, Mandel C, Forder PM, Hong A, Hruby G, Burmeister B, Shivalingam B, Dhillon H, Thompson JF, BMC Cancer 2011 11 142 10.1186/1471-2407-11-142 21496312
8. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B, JAMA 1998 280 1485 1489 9809728 (Pubitemid 28507400)
9. Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G, JAMA 2006 295 2483 2491 10.1001/jama.295.21.2483 16757720 (Pubitemid 43854963)
10. Adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebralmetastases: results of the EORTC 22952-26001 study. Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP, J Clin Oncol 2011 29 134 141 10.1200/JCO.2010.30.1655 21041710
11. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA, Lancet Oncol 2009 10 11 1037 1044 10.1016/S1470-2045(09)70263-3 19801201
12. Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05). Roos DE, Wirth A, Burmeister BH, Spry NA, Drummond KJ, Beresford JA, McClure BE, Radiother Oncol 2006 80 3 318 322 10.1016/j.radonc.2006.08.004 16956684 (Pubitemid 44397210)